|
TMED7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.933800E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.071400E-01 |
| Normal-vs-Stage2 |
8.626200E-01 |
| Normal-vs-Stage3 |
1.607400E-01 |
| Normal-vs-Stage4 |
6.281900E-03 |
| Stage1-vs-Stage2 |
4.300400E-01 |
| Stage1-vs-Stage3 |
6.289800E-01 |
| Stage1-vs-Stage4 |
5.074000E-02 |
| Stage2-vs-Stage3 |
3.236000E-01 |
| Stage2-vs-Stage4 |
8.952300E-02 |
| Stage3-vs-Stage4 |
2.666600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.480000E-01 |
| Normal-vs-AfricanAmerican |
7.37359999725129E-08 |
| Normal-vs-Asian |
1.641600E-01 |
| Caucasian-vs-AfricanAmerican |
2.90699999627719E-08 |
| Caucasian-vs-Asian |
5.393000E-01 |
| AfricanAmerican-vs-Asian |
2.403200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.728400E-02 |
| Normal-vs-Female |
2.522800E-01 |
| Male-vs-Female |
6.279200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.263260E-03 |
| Normal-vs-Age(41-60Yrs) |
2.391600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.174630E-01 |
| Normal-vs-Age(81-100Yrs) |
7.826800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.898200E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.073510E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.106000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.765000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.433200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.940800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.624400E-01 |
| Normal-vs-Grade 2 |
7.136200E-01 |
| Normal-vs-Grade 3 |
1.130410E-01 |
| Normal-vs-Grade 4 |
1.231890E-04 |
| Grade 1-vs-Grade 2 |
3.953400E-01 |
| Grade 1-vs-Grade 3 |
7.807000E-01 |
| Grade 1-vs-Grade 4 |
2.680800E-01 |
| Grade 2-vs-Grade 3 |
2.384200E-01 |
| Grade 2-vs-Grade 4 |
6.813400E-04 |
| Grade 3-vs-Grade 4 |
3.761200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.476600E-01 |
| Normal-vs-ccB subtype |
2.413900E-02 |
| ccA subtype-vs-ccB subtype |
7.568000E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.544000E-01 |
| Normal-vs-N1 |
2.386000E-01 |
| N0-vs-N1 |
4.096400E-01 |
|
|
